Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.
about
Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-AnalysisBiomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all.NT-ProBNP levels in saliva and its clinical relevance to heart failure.Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis.Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitusElevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohortBiomarkers of hemodynamic stress and aortic stiffness after STEMI: a cross-sectional analysis.Admission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failure.N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort StudyCharacterization of Relaxant Responses to Natriuretic Peptides in the Human Microcirculation In Vitro and In Vivo.B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men.Clinical value of plasma B-type natriuretic peptide assay in pediatric pneumonia accompanied by heart failurePlasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytomaPlasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volumeTranscatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes.Nutrient sensing and utilization: Getting to the heart of metabolic flexibility.Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction.Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomyHigher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.Role of brain natriuretic peptide as a novel prognostic biomarker in acute ischemic strokeIncomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot studyBrain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.Effect of acute endurance and resistance exercise on endocrine hormones directly related to lipolysis and skeletal muscle protein synthesis in adult individuals with obesity.Non-genomic effect of glucocorticoids on cardiovascular system.Natriuretic peptides and cGMP signaling control of energy homeostasis.Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist.Changes in hypothalamus-pituitary-adrenal axis following transient ischemic attack.The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.Natriuretic peptide testing in high-risk pregnancy: a preventive opportunity?State of the art of immunoassay methods for B-type natriuretic peptides: An update.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?Hypoxia regulates the natriuretic peptide system.Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure.GDF15 is a heart-derived hormone that regulates body growthAtrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.Systemic control of brown fat thermogenesis: integration of peripheral and central signals.
P2860
Q26798401-9FDAB01D-6427-4CAB-81AF-B1F674F05D89Q33750340-5BEEC8AB-5A96-406A-9B19-2F284BE7A7C6Q34465119-DA917F8E-5566-445A-ABE5-000182BCBB33Q34558277-B1ED7E7D-3888-4B30-99BB-77AB10BD7126Q35127306-653DE676-C71D-4009-B6DC-0D41DDF9BF56Q35219570-B6FD5276-7AD2-4783-AFB6-A1A32F8B2034Q35556679-47298D31-E0EA-409E-8273-BFF4957100EAQ35724664-3E30079D-1740-4F07-9864-CA68774B5E70Q35801673-3FF82E2E-C262-4839-A91D-D5F1D4C6C3F3Q36024926-1FDDD85D-5A20-43E8-B43F-CEEBBD836A9AQ36249721-A04AFFD2-5AD8-4AB7-A590-9345380C4CBAQ36334557-600E619E-42EC-49C3-A11B-8E03211DBE59Q36336338-BD7FDA76-E0CB-493B-BE96-079A1A450108Q36501539-9328A6DB-A4B0-4A24-A955-298712518395Q36690586-4F2DCD0A-A201-4ABD-8617-581870276D99Q36788620-D4213CEB-77A7-412D-9E9F-74A9223ADB1BQ36825438-9C194604-FF23-4ED1-9AC6-D33EC6E87300Q36922698-8F5DF885-AE06-4BF1-87E4-C5FD18BC666BQ37023112-A8F1C7E3-9435-4710-8D4B-D436F7768F7BQ37108587-F3E6802A-B9DD-4CA1-B465-B92AC8B0EFFBQ37378648-3B9F417A-6CF4-4B5A-86CE-7F0F11265329Q37484379-0DAA28CA-C978-48A4-A84B-2037140788F5Q37616178-FE1DEBA2-8E98-42DC-ABA8-BF0FA9CA39F8Q37980254-823EB959-30A0-487F-9041-2D0E1FFCD997Q37997795-01FC05A1-9EC9-4BC0-A342-4040BBCA6C75Q38045751-16626865-3023-451A-B3B6-4573A6C244C2Q38064374-2B7F970D-7DB8-4A14-9469-EB20750622FEQ38120091-68E6966C-D873-4A7D-AD75-3F671D7A56E8Q38142904-D2906434-3FD2-4830-AE2E-9070AF2750BCQ38182858-631A4E77-4659-4DB1-ADA3-CA244A6DC6E7Q38254725-EAC2C0EF-05BE-4CBD-AA2F-4DC6B7473B9CQ38303192-86DBF781-3866-47AA-A99A-F8F0D974EA8DQ38324210-6DD108E8-64B2-4F77-9D3F-C369672A999CQ38510432-90AEDB48-4459-4D80-9E41-1435C776EB84Q38837698-0B1E782E-24FD-4640-B206-DC54C44EF03BQ40954684-EF3C9314-F363-49D4-9DAE-57720FF3A07DQ41083010-65233FED-0FF6-4414-B643-222B2CB45BA2Q41198863-40F69E65-7122-43C0-9C23-C63386A18EECQ41511312-C6979A72-A0DC-456C-B1B5-D58156441F51Q42132608-6E140494-0331-428D-9D62-CC0A9091FB63
P2860
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@en
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@nl
type
label
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@en
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@nl
prefLabel
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@en
Thirty years of the heart as a ...... cardiac natriuretic hormones.
@nl
P2860
P1476
Thirty years of the heart as a ...... f cardiac natriuretic hormones
@en
P2093
Aldo Clerico
Simona Vittorini
P2860
P304
P356
10.1152/AJPHEART.00226.2011
P577
2011-05-06T00:00:00Z